SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-09-058617
Filing Date
2009-11-06
Accepted
2009-11-05 19:12:08
Documents
5
Period of Report
2009-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w76177e8vk.htm 8-K 11543
2 EX-99.1 w76177exv99w1.htm EX-99.1 88331
3 GRAPHIC w76177w7617701.gif GRAPHIC 2091
4 GRAPHIC w76177w7617702.gif GRAPHIC 4764
5 GRAPHIC w76177w7617703.gif GRAPHIC 2753
  Complete submission text file 0000950123-09-058617.txt   115091
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 091162448
SIC: 2834 Pharmaceutical Preparations